News Global Drug Pricing and Market Access: What to Expect in 2022 Feb 09, 2022 Posted by Sidley Austin
News InSphero Further Strengthens Scientific Advisory Board for Liver Diseases by Appointing Professor Nikolai Naoumov Feb 09, 2022 Posted by InSphero
News Cyteir Therapeutics Announces First Patient Dosed in Phase 2 with CYT-0851 Feb 08, 2022 Posted by Cyteir Therapeutics
News Medical Device Companies Take Note: FDA’s Proposed Rule to Align ISO 13485 With its Quality System Regulation Moves Forward Feb 07, 2022 Posted by Sidley Austin
News Cyteir Therapeutics Announces the Appointment of John F. Thero to Board of Directors Feb 07, 2022 Posted by Cyteir Therapeutics
